Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Guirakhoo is Chief Scientific Officer (CSO) at GeoVax, Inc. He was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignments were Chief Technology Officer at Vaxess Technologies and CSO at Hookipa Biotech. Prior to that, Dr. Guirakhoo held the position of Executive Director of External R&D at Sanofi Pasteur. Before joining Sanofi Pasteur, Dr. Guirakhoo was Head of Virology Research at Acambis for 15 years. During this time, he co-invented the ChimeriVax™ technology platform in association with St. Louis University which was successfully used in the development of innovative vaccines such as IMOJEV™, against Japanese encephalitis (Sanofi), PREVNILE™, veterinary vaccine for the prevention of West Nile encephalitis (Merck Animal Health) and DENGVAXIA® (Sanofi). Dr. Guirakhoo has over 30 years of experience in vaccine development infectious and holds a BSc in Biology, a MSc in genetics, and a PhD in Virology.